Evidence map›Paper›PMID 20827404›Full record

ArticleHepatology international2010

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Masao Omata, Laurentius A Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T P Poon and 15 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Hepatology international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 486 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
486citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03261791 phase2unknown statusnot on this mapstarted 2017, after this paper: background citation

A Exploratory Study of Apatinib Adjuvant Therapy for Hepatocellular Carcinoma With Portal Vein Invasion Who Underwent Radical Resection

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2017 to 2020Enrolled30ConditionsCarcinoma, HepatocellularArmsApatinib
NCT03322280 naunknown statusnot on this mapstarted 2018, after this paper: background citation

TACE Combined With Iodine-125 Seeds Implantation Versus TACE Alone for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective, Multicenter, Randomized, Controlled Study

TypeinterventionalSponsorSecond Affiliated Hospital of Guangzhou Medical UniversityRan2018 to 2022Enrolled270ConditionsHepatocellular Carcinoma, Portal Vein Occlusion, Tumor ThrombusArmsTACE combined with iodine-125 seeds implantation, TACE
NCT06294808 completednot on this mapstarted 2017, after this paper: background citation

Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC: a Metroticket Approach

TypeobservationalSponsorNational Cancer Centre, SingaporeRan2017 to 2020Enrolled1,043ConditionsHepatocellular Carcinoma Resectable
3 · Its place in the literature

Who cites it

486 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

426 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Masao Omata
Laurentius A Lesmana
Ryosuke Tateishi
Pei-Jer Chen
Shi-Ming Lin
Haruhiko Yoshida
Masatoshi Kudo
Jeong Min Lee
Byung Ihn Choi
Ronnie T P Poon
Shuichiro Shiina
Ann Lii Cheng
Ji-Dong Jia
Shuntaro Obi
Kwang Hyub Han
Wasim Jafri
Pierce Chow
Seng Gee Lim
Yogesh K Chawla
Unggul Budihusodo
Rino A Gani
C Rinaldi Lesmana
Terawan Agus Putranto
Yun Fan Liaw
Shiv Kumar Sarin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations.

methodsThe working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements.

resultsParticipants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.

Indexed as

Consensus statementsDiagnosisEpidemiologyHepatocellular carcinomaRecommendationsTreatment algorithm

Identifiers

PMID20827404
PMCPMC2900561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.